PE20090299A1 - Antagonistas cxcr4 de peptido ciclicos - Google Patents
Antagonistas cxcr4 de peptido ciclicosInfo
- Publication number
- PE20090299A1 PE20090299A1 PE2008000868A PE2008000868A PE20090299A1 PE 20090299 A1 PE20090299 A1 PE 20090299A1 PE 2008000868 A PE2008000868 A PE 2008000868A PE 2008000868 A PE2008000868 A PE 2008000868A PE 20090299 A1 PE20090299 A1 PE 20090299A1
- Authority
- PE
- Peru
- Prior art keywords
- lys
- glu
- cxcr4 antagonists
- naphthylalanine
- gly
- Prior art date
Links
- 229940121384 cxc chemokine receptor type 4 (cxcr4) antagonist Drugs 0.000 title abstract 2
- 108010069514 Cyclic Peptides Proteins 0.000 title 1
- 102000001189 Cyclic Peptides Human genes 0.000 title 1
- -1 AMINO GROUP Chemical group 0.000 abstract 4
- RWLSBXBFZHDHHX-VIFPVBQESA-N (2s)-2-(naphthalen-2-ylamino)propanoic acid Chemical compound C1=CC=CC2=CC(N[C@@H](C)C(O)=O)=CC=C21 RWLSBXBFZHDHHX-VIFPVBQESA-N 0.000 abstract 2
- 150000003951 lactams Chemical class 0.000 abstract 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical class C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
- 201000003068 rheumatic fever Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94080207P | 2007-05-30 | 2007-05-30 | |
| US94099607P | 2007-05-31 | 2007-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090299A1 true PE20090299A1 (es) | 2009-03-19 |
Family
ID=39831600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008000868A PE20090299A1 (es) | 2007-05-30 | 2008-05-20 | Antagonistas cxcr4 de peptido ciclicos |
Country Status (32)
| Country | Link |
|---|---|
| US (3) | US7691813B2 (OSRAM) |
| EP (2) | EP2160221B1 (OSRAM) |
| JP (1) | JP5358564B2 (OSRAM) |
| KR (2) | KR101319740B1 (OSRAM) |
| CN (1) | CN101678213B (OSRAM) |
| AR (1) | AR066648A1 (OSRAM) |
| AT (1) | ATE516853T1 (OSRAM) |
| AU (1) | AU2008260326B2 (OSRAM) |
| BR (1) | BRPI0812134A2 (OSRAM) |
| CA (1) | CA2688574C (OSRAM) |
| CL (1) | CL2008001467A1 (OSRAM) |
| CO (1) | CO6241137A2 (OSRAM) |
| CR (1) | CR11105A (OSRAM) |
| CY (1) | CY1111815T1 (OSRAM) |
| DK (1) | DK2160221T3 (OSRAM) |
| DO (1) | DOP2009000270A (OSRAM) |
| EA (1) | EA017716B1 (OSRAM) |
| GT (1) | GT200900304A (OSRAM) |
| HR (1) | HRP20110551T1 (OSRAM) |
| IL (1) | IL201685A (OSRAM) |
| JO (1) | JO2776B1 (OSRAM) |
| MA (1) | MA31666B1 (OSRAM) |
| MX (1) | MX2009012952A (OSRAM) |
| MY (1) | MY149432A (OSRAM) |
| NZ (1) | NZ580849A (OSRAM) |
| PE (1) | PE20090299A1 (OSRAM) |
| PL (1) | PL2160221T3 (OSRAM) |
| PT (1) | PT2160221E (OSRAM) |
| TN (1) | TN2009000496A1 (OSRAM) |
| TW (1) | TWI423987B (OSRAM) |
| WO (1) | WO2008150689A1 (OSRAM) |
| ZA (1) | ZA200908345B (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2942798B1 (fr) * | 2009-03-05 | 2011-04-08 | Centre Nat Rech Scient | Peptides utilisables pour le traitement de la leucemie lymphoide chronique |
| IT1397901B1 (it) * | 2010-01-26 | 2013-02-04 | Consiglio Nazionale Ricerche | Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico. |
| JPWO2012118124A1 (ja) * | 2011-03-01 | 2014-07-07 | 国立大学法人京都大学 | 新規ケモカイン受容体拮抗剤 |
| WO2012168336A1 (en) * | 2011-06-07 | 2012-12-13 | Polyphor Ag | Beta - hairpin peptidomimetics as cxc4 antagonists |
| CN104780930A (zh) * | 2011-09-30 | 2015-07-15 | 程云 | 丙型肝炎病毒免疫原性肽或其衍生物在预防或治疗关节炎中的应用 |
| EP2771484A1 (en) | 2011-10-28 | 2014-09-03 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
| EP2979991A1 (en) | 2014-07-31 | 2016-02-03 | Greif International Holding BV. | Multilayer material, fire protection mat with said multilayer material and transport and storage container assembly comprising said fire protection mat. |
| ES2764840T3 (es) | 2015-01-28 | 2020-06-04 | Univ Bordeaux | Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica |
| WO2017176565A1 (en) | 2016-04-07 | 2017-10-12 | Eli Lilly And Company | Combinations of an anti-b7-h1 antibody and a cxcr4 peptide antagonist for treating a solid tumor |
| CN109922818B (zh) * | 2016-09-06 | 2024-02-20 | 主线生物科学公司 | Cxcr4拮抗剂及使用方法 |
| CN106841624B (zh) * | 2017-01-26 | 2019-02-22 | 庄磊靓 | 抗人cd4和抗人cd184单克隆抗体作为标志物的应用 |
| KR20200043970A (ko) * | 2017-09-05 | 2020-04-28 | 메인라인 바이오사이언스 | 고친화성 cxcr4 선택적 결합 콘쥬게이트 및 그 사용 방법 |
| US11123437B2 (en) | 2017-09-05 | 2021-09-21 | Mainline Biosciences, Inc. | Selective CXCR4 binding peptide conjugate and methods for making and using the same |
| WO2019126796A1 (en) * | 2017-12-21 | 2019-06-27 | Mainline Biosciences Llc | Composition comprising a therapeutic agent and a cxcr4 selective antagonist and methods for using the same |
| JP2021165234A (ja) * | 2018-07-03 | 2021-10-14 | 富士フイルム富山化学株式会社 | Ｃｘｃｒ４結合性化合物もしくはその塩またはそれらと金属との錯体 |
| US11639373B2 (en) | 2018-09-12 | 2023-05-02 | Technische Universität München | Therapeutic and diagnostic agents for cancer |
| CA3108450A1 (en) | 2018-09-12 | 2020-03-19 | Technische Universitat Munchen | Cxcr4-targeted diagnostic and therapeutic agents with reduced species selectivity |
| JP7541532B2 (ja) * | 2019-04-18 | 2024-08-28 | プロビンシャル・ヘルス・サービシーズ・オーソリティ | 診断及び治療のための新規な放射性標識されたｃｘｃｒ４を標的とする化合物 |
| EP4097120A4 (en) * | 2020-01-26 | 2024-05-01 | Mainline Biosciences (Shanghai) Co., Ltd. | ISOTOPE-LABELED CXCR4 SELECTIVELY BINDING PEPTIDE CONJUGATE AND METHODS OF MAKING AND USE THEREOF |
| WO2022082312A1 (en) * | 2020-10-21 | 2022-04-28 | Provincial Health Services Authority | Novel cxcr4-targeting compounds |
| TW202235429A (zh) * | 2020-12-25 | 2022-09-16 | 日商中外製藥股份有限公司 | 含ｎ－置換－胺基酸殘基之胜肽化合物的製備方法 |
| CN116615411A (zh) * | 2020-12-25 | 2023-08-18 | 中外制药株式会社 | 包含n-取代氨基酸残基的肽化合物的制造方法 |
| EP4043041A1 (en) | 2021-02-15 | 2022-08-17 | Technische Universität München | Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof |
| CN119325480A (zh) * | 2022-04-20 | 2025-01-17 | 省卫生服务机构 | 靶向cxcr4的化合物及其制备和使用方法 |
| CN115060901A (zh) * | 2022-06-21 | 2022-09-16 | 中国医学科学院基础医学研究所 | 苹果酸酶2在制备矽肺病或肺纤维化相关疾病诊断试剂或治疗药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4391123B2 (ja) * | 2002-10-24 | 2009-12-24 | 株式会社オーファンリンク | 新規ｃｘｃｒ４アンタゴニスト |
| CA2643744A1 (en) * | 2006-02-27 | 2007-08-30 | Technische Universitaet Muenchen | Cancer imaging and treatment |
-
2008
- 2008-05-20 KR KR1020117026680A patent/KR101319740B1/ko not_active Expired - Fee Related
- 2008-05-20 AR ARP080102137A patent/AR066648A1/es unknown
- 2008-05-20 AT AT08769524T patent/ATE516853T1/de active
- 2008-05-20 EP EP08769524A patent/EP2160221B1/en active Active
- 2008-05-20 TW TW097118554A patent/TWI423987B/zh not_active IP Right Cessation
- 2008-05-20 MX MX2009012952A patent/MX2009012952A/es active IP Right Grant
- 2008-05-20 HR HR20110551T patent/HRP20110551T1/hr unknown
- 2008-05-20 CN CN2008800178577A patent/CN101678213B/zh not_active Expired - Fee Related
- 2008-05-20 AU AU2008260326A patent/AU2008260326B2/en not_active Ceased
- 2008-05-20 JO JO2008229A patent/JO2776B1/en active
- 2008-05-20 PL PL08769524T patent/PL2160221T3/pl unknown
- 2008-05-20 KR KR1020097024829A patent/KR101169846B1/ko not_active Expired - Fee Related
- 2008-05-20 EP EP11172401A patent/EP2377579A1/en not_active Withdrawn
- 2008-05-20 BR BRPI0812134-6A2A patent/BRPI0812134A2/pt not_active IP Right Cessation
- 2008-05-20 EA EA200971129A patent/EA017716B1/ru not_active IP Right Cessation
- 2008-05-20 CL CL2008001467A patent/CL2008001467A1/es unknown
- 2008-05-20 JP JP2010510418A patent/JP5358564B2/ja not_active Expired - Fee Related
- 2008-05-20 NZ NZ580849A patent/NZ580849A/en not_active IP Right Cessation
- 2008-05-20 CA CA2688574A patent/CA2688574C/en not_active Expired - Fee Related
- 2008-05-20 MY MYPI20095053A patent/MY149432A/en unknown
- 2008-05-20 PE PE2008000868A patent/PE20090299A1/es not_active Application Discontinuation
- 2008-05-20 DK DK08769524.3T patent/DK2160221T3/da active
- 2008-05-20 US US12/123,574 patent/US7691813B2/en not_active Ceased
- 2008-05-20 PT PT08769524T patent/PT2160221E/pt unknown
- 2008-05-20 WO PCT/US2008/064177 patent/WO2008150689A1/en not_active Ceased
-
2009
- 2009-10-22 IL IL201685A patent/IL201685A/en not_active IP Right Cessation
- 2009-11-10 CR CR11105A patent/CR11105A/es not_active Application Discontinuation
- 2009-11-25 ZA ZA2009/08345A patent/ZA200908345B/en unknown
- 2009-11-26 GT GT200900304A patent/GT200900304A/es unknown
- 2009-11-26 TN TNP2009000496A patent/TN2009000496A1/fr unknown
- 2009-11-27 DO DO2009000270A patent/DOP2009000270A/es unknown
- 2009-11-27 CO CO09135750A patent/CO6241137A2/es active IP Right Grant
- 2009-12-21 MA MA32439A patent/MA31666B1/fr unknown
-
2010
- 2010-01-25 US US12/692,788 patent/US20100130409A1/en not_active Abandoned
- 2010-09-10 US US12/807,694 patent/USRE42274E1/en not_active Expired - Fee Related
-
2011
- 2011-09-07 CY CY20111100861T patent/CY1111815T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090299A1 (es) | Antagonistas cxcr4 de peptido ciclicos | |
| ES2566830T3 (es) | Péptido capaz de extender la semivida de péptido de interés en plasma | |
| ES2548767T3 (es) | Nuevos péptidos antimicrobianos | |
| JP2010529957A5 (OSRAM) | ||
| NZ603811A (en) | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases | |
| EA202190134A1 (ru) | Соединения аминокислот с неразветвленными линкерами и способы их применения | |
| PE20140159A1 (es) | Coagonistas del receptor de glucagon/glp-1 | |
| PE20100255A1 (es) | Co-agonistas del receptor de glucagon/glp-1 | |
| CA2648109A1 (en) | Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine | |
| CY1113115T1 (el) | Πεπτιδια - αναστολεις συντηξης του ηiv με βελτιωμενες βιολογικες ιδιοτητες | |
| DE69938064D1 (de) | Aminoterminal modifizierte parathyroidhormon (pth) analoge | |
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| RU2013101051A (ru) | Новый пептид и его применение | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| Lohani et al. | Solid-phase synthesis and in vitro biological activity of a Thr4→ Ser4 analog of daptomycin | |
| RU2011101391A (ru) | Ингибиторы пептидиларгининдезиминазы (pad) | |
| PE20040724A1 (es) | Composicion para la administracion oral de calcitonina | |
| Koizumi et al. | Structure–activity relationship of cyclic pentapeptide malformins as fibrinolysis enhancers | |
| CN107531803B (zh) | 环状甘丙肽类似物及其用途 | |
| NO20082127L (no) | Antagonister mot interaksjon av PF4 og Rantes | |
| WO2007125142A8 (es) | Péptidos lineales antimicrobianos | |
| IN2014MN02080A (OSRAM) | ||
| WO2008070049A8 (en) | Peptide and treatment for hiv-1 infection | |
| ATE529440T1 (de) | Biologisch aktives peptid und wirkstoff, der dieses enthält | |
| Zhao et al. | Synthesis and thrombolytic activity of fibrinogen fragment related cyclopeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |